Medulloblastoma surgery

Revision as of 02:34, 27 November 2017 by Mmir (talk | contribs) (Mahshid)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Medulloblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Medulloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Medulloblastoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Medulloblastoma surgery

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Medulloblastoma surgery

CDC on Medulloblastoma surgery

Medulloblastoma surgery in the news

Blogs on Medulloblastoma surgery

Directions to Hospitals Treating Medulloblastoma

Risk calculators and risk factors for Medulloblastoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Surgical intervention alone is not recommended as a single therapeutic modality for the management of medulloblastoma. According to the risk stratification criterion for medulloblastoma patients, surgery must be followed by the appropriate radiotherapy or chemotherapy management. Surgical excision of medulloblastoma may be done either via a posterior fossa craniectomy approach or a suboccipital craniectomy approach. Complications related to surgery may include aseptic meningitis, haematoma formation, and posterior fossa syndrome.[1]

Surgery

  • Surgical intervention alone is not recommended as a single therapeutic modality for the management of medulloblastoma.[1]
  • Surgical excision of medulloblastoma may be done either via:
  • The two main objectives of medulloblastoma surgical excision are:
  • Intraoperative gentle suction of medulloblastoma is preferred over surgical dissection due to the friable nature of the mass.
  • A ventriculoperitoneal shunt may be inserted in 50% of the cases following surgery to manage refractory hydrocephalus.
  • A criticism of pre-operative ventriculoperitoneal shunts is that they may promote the metastatic spread of medulloblastoma.[2]
  • Surgical complications may include:

References

  1. 1.0 1.1 Bartlett F, Kortmann R, Saran F (2013). "Medulloblastoma". Clin Oncol (R Coll Radiol). 25 (1): 36–45. doi:10.1016/j.clon.2012.09.008. PMID 23245832.
  2. Intracranial tumours, infections, and aneurysms. SurgWiki (2015) http://www.surgwiki.com/wiki/Intracranial_tumours,_infection_and_aneurysms#Paediatric_brain_tumours#Management Accessed on October 6, 2015.


Template:WikiDoc Sources